title: [Activity and efficacy of vinflunine in metastatic carcinoma of the bladder after failure of adjuvant treatment: description of a clinical case].
abstract: Vinflunine is the only drug tested in a phase III trial and, to date, approved for advanced or metastatic bladder cancer after failure of a prior platinum-containing regimen. We report a case of a man with metastatic bladder cancer treated with vinflunine after failure of an adjuvant chemotherapy with carboplatin and gemcitabine.
authors.forename: Franco
authors.initials: F
authors.lastname: Morelli
mesh_terms: D000368:Aged; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002295:Carcinoma, Transitional Cell / Q000188:drug therapy* / Q000556:secondary / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D015653:Cystectomy / Q000379:methods; D018450:Disease Progression; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D014747:Vinblastine / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; C111217:vinflunine; D014747:Vinblastine